605116 奥锐特
已收盘 11-22 15:00:00
资讯
新帖
简况
奥锐特:业绩说明会定于12月2日举行
每日经济新闻 · 22分钟前
奥锐特:业绩说明会定于12月2日举行
奥锐特11月22日获主力加仓384万元 环比增加1645.45%
市场透视 · 15:19
奥锐特11月22日获主力加仓384万元 环比增加1645.45%
奥锐特:11月19日高管邱培静减持股份合计25万股
证券之星 · 11-20 20:01
奥锐特:11月19日高管邱培静减持股份合计25万股
奥锐特:11月11日高管邱培静减持股份合计9.67万股
证券之星 · 11-12
奥锐特:11月11日高管邱培静减持股份合计9.67万股
奥锐特:11月8日高管邱培静减持股份合计16.94万股
证券之星 · 11-11
奥锐特:11月8日高管邱培静减持股份合计16.94万股
奥锐特(605116)207.8万股限售股将于11月7日解禁,占总股本0.51%
证券之星 · 11-07
奥锐特(605116)207.8万股限售股将于11月7日解禁,占总股本0.51%
奥锐特:业绩稳健、基数扰动 关注司美和制剂增量
中信建投证券 · 11-01
奥锐特:业绩稳健、基数扰动 关注司美和制剂增量
奥锐特10月31日主力资金流入136万元 连续3日加仓
市场透视 · 10-31
奥锐特10月31日主力资金流入136万元 连续3日加仓
奥锐特:季度有波动 能力仍稀缺
浙商证券 · 10-31
奥锐特:季度有波动 能力仍稀缺
太平洋:给予奥锐特买入评级,目标价位28.0元
证券之星 · 10-27
太平洋:给予奥锐特买入评级,目标价位28.0元
开源证券:给予奥锐特买入评级
证券之星 · 10-25
开源证券:给予奥锐特买入评级
奥锐特大跌5.19% 6家券商给予增持建议
智选洞察 · 10-25
奥锐特大跌5.19% 6家券商给予增持建议
奥锐特(605116.SH)发前三季业绩,净利润2.84亿元,同比增长22.04%
智通财经 · 10-24
奥锐特(605116.SH)发前三季业绩,净利润2.84亿元,同比增长22.04%
奥锐特大跌5.03% 获主力净流入137万元
智选洞察 · 10-11
奥锐特大跌5.03% 获主力净流入137万元
奥锐特大跌5.11% 获主力净流入增加
智选洞察 · 10-09
奥锐特大跌5.11% 获主力净流入增加
奥锐特10月08日主力资金流出1209万元 连续3日减仓
市场透视 · 10-08
奥锐特10月08日主力资金流出1209万元 连续3日减仓
奥锐特创2个月新高 获主力净流入421万元
智选洞察 · 10-08
奥锐特创2个月新高 获主力净流入421万元
奥锐特09月30日遭主力抛售1461万元 环比增加769.64%
市场透视 · 09-30
奥锐特09月30日遭主力抛售1461万元 环比增加769.64%
奥锐特大幅上涨 2024河南与跨国公司合作交流会举行
智选洞察 · 09-27
奥锐特大幅上涨 2024河南与跨国公司合作交流会举行
奥锐特09月23日主力资金流入196万元 连续3日加仓
市场透视 · 09-23
奥锐特09月23日主力资金流入196万元 连续3日加仓
加载更多
公司概况
公司名称:
奥锐特药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-09-21
主营业务:
奥锐特药业股份有限公司主营业务是特色原料药和医药中间体的研发、生产和销售。主要产品为呼吸系统类、心血管类、抗感染类和神经系统类药物,包括氟美松、丙酸氟替卡松、依普利酮、替诺福韦、普瑞巴林等原料药和中间体。公司已经通过了包括NMPA、FDA、WHO、BGV等监管机构的认证,目前已经有1个产品通过WHO的审计,4个产品取得欧盟CEP认证,3个产品取得了欧盟GMP证书,5个产品取得了出口欧盟的证明,11个产品已经提交了美国DMF文件,建立了独具竞争力的自主品牌,成为国内出口特色原料药较多的企业之一。
发行价格:
8.37
{"stockData":{"symbol":"605116","market":"SH","secType":"STK","nameCN":"奥锐特","latestPrice":21.12,"timestamp":1732258801000,"preClose":21.9,"halted":0,"volume":1824100,"delay":0,"floatShares":398000000,"shares":405999999,"eps":0.8387,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.78,"latestTime":"11-22 15:00:00","open":21.9,"high":21.9,"low":21.1,"amount":39199000,"amplitude":0.0365,"askPrice":21.13,"askSize":212,"bidPrice":21.12,"bidSize":296,"shortable":0,"etf":0,"ttmEps":0.8387,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":21.9,"symbolType":"stock","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":24.09,"lowLimit":19.71,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":406195000,"pbRate":3.93,"roa":"--","roe":"13.75%","epsLYR":0.71,"committee":0.21608,"marketValue":8579000000,"floatMarketCap":8395000000,"peRate":25.181829,"changeRate":-0.0356,"turnoverRate":0.0046,"status":1},"requestUrl":"/m/hq/s/605116","defaultTab":"news","newsList":[{"id":"2485233999","title":"奥锐特:业绩说明会定于12月2日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2485233999","media":"每日经济新闻","labels":["Important Conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485233999?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:14","pubTimestamp":1732263267,"startTime":"0","endTime":"0","summary":"每经AI快讯,奥锐特 11月22日晚间发布公告称,公司2024年第三季度业绩说明会定于2024年12月02日下午15:00-16:00,以上证路演中心网络互动的形式进行。2023年1至12月份,奥锐特的营业收入构成为:自产原料药及中间体占比83.86%,贸易占比8.34%,制剂占比7.12%。奥锐特的总经理是褚定军,男,51岁,学历背景为本科。截至发稿,奥锐特市值为86亿元。道达号“个股趋势”提醒:1. 近30日内无机构对奥锐特进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122161540a24d64be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122161540a24d64be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Important Conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2485287672","title":"奥锐特11月22日获主力加仓384万元 环比增加1645.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485287672","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485287672?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:19","pubTimestamp":1732259973,"startTime":"0","endTime":"0","summary":"11月22日, 奥锐特股价跌3.56%,报收21.12元,成交金额3919万元,换手率0.46%,振幅3.65%,量比0.97。奥锐特今日主力资金净流入384万元,连续3日净流入,上一交易日主力净流入22万元,今日环比增加1645.45%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为41.67%,平均涨幅为2.19%。该股近5个交易日下跌3.56%,主力资金累计净流入281万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入31万元,其中净流入天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122153131abd6b90f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122153131abd6b90f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2484885197","title":"奥锐特:11月19日高管邱培静减持股份合计25万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2484885197","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484885197?lang=zh_cn&edition=full","pubTime":"2024-11-20 20:01","pubTimestamp":1732104075,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月20日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年11月19日公司董事邱培静共减持公司股份25.0万股,占公司总股本为0.0615%。变动期间公司股价上涨1.35%,11月19日当日收盘报21.71元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.08。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112000034901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2482708022","title":"奥锐特:11月11日高管邱培静减持股份合计9.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482708022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482708022?lang=zh_cn&edition=full","pubTime":"2024-11-12 20:01","pubTimestamp":1731412889,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月12日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年11月11日公司董事邱培静共减持公司股份9.67万股,占公司总股本为0.0238%。变动期间公司股价上涨0.26%,11月11日当日收盘报22.86元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.08。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200033639.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2482200717","title":"奥锐特:11月8日高管邱培静减持股份合计16.94万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482200717","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482200717?lang=zh_cn&edition=full","pubTime":"2024-11-11 20:01","pubTimestamp":1731326488,"startTime":"0","endTime":"0","summary":"证券之星消息,根据11月11日市场公开信息、上市公司公告及交易所披露数据整理,奥锐特(605116)最新董监高及相关人员股份变动情况:2024年11月8日公司董事邱培静共减持公司股份16.94万股,占公司总股本为0.0417%。变动期间公司股价上涨1.69%,11月8日当日收盘报22.8元。奥锐特近半年内的董监高及核心技术人员增减持详情如下:奥锐特的高管列表及最新持股情况如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为28.81。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111100026429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2481601479","title":"奥锐特(605116)207.8万股限售股将于11月7日解禁,占总股本0.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481601479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481601479?lang=zh_cn&edition=full","pubTime":"2024-11-07 08:04","pubTimestamp":1730937887,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,奥锐特于11月7日将有207.8万股限售股份解禁,为公司股权激励限售股份,占公司总股本0.51%。本次解禁后,公司还有868.4万股限售股份,占总股本2.14%。奥锐特主营业务:特色复杂原料药、医药中间体和制剂的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700006787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2480719530","title":"奥锐特:业绩稳健、基数扰动 关注司美和制剂增量","url":"https://stock-news.laohu8.com/highlight/detail?id=2480719530","media":"中信建投证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480719530?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:00","pubTimestamp":1730390400,"startTime":"0","endTime":"0","summary":"公司业绩整体符合预期,年初至今收入及利润均保持良好增长态势。原料药预计保持稳健增长。公司制剂业务在上半年表现良好,且Q3 单季度公司毛利率环比仍呈现提升趋势,我们预计与制剂业务销售推广带来的进一步放量有关。24Q3 公司雌二醇片/雌二醇地屈孕酮片复合包装上市申请已获受理,后续制剂业务持续放量值得关注。行业竞争加剧风险:目前公司主要竞争对手为欧美和印度、中国等国的特色原料药和制剂生产企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202411011657199f58fdcf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202411011657199f58fdcf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2479720895","title":"奥锐特10月31日主力资金流入136万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2479720895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479720895?lang=zh_cn&edition=full","pubTime":"2024-10-31 15:18","pubTimestamp":1730359080,"startTime":"0","endTime":"0","summary":"10月31日, 奥锐特股价跌1.56%,报收22.15元,成交金额6083万元,换手率0.69%,振幅2.09%,量比0.77。奥锐特今日主力资金净流入136万元,连续3日净流入,上一交易日主力净流入130万元,今日环比增加4.62%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为36.36%,平均涨幅为2.51%。该股近5个交易日下跌6.46%,主力资金累计净流入578万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出2710万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031152753a20003d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031152753a20003d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2479084582","title":"奥锐特:季度有波动 能力仍稀缺","url":"https://stock-news.laohu8.com/highlight/detail?id=2479084582","media":"浙商证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479084582?lang=zh_cn&edition=full","pubTime":"2024-10-31 00:00","pubTimestamp":1730304000,"startTime":"0","endTime":"0","summary":"拉长看公司 Q1-Q3 单季度毛利率延续环比提升态势,且同行业比较看,公司单Q3 毛利率&净利率均处于行业前5 名,盈利能力表现亮眼。单Q3 销售费用率下降抵减毛利率下降以及财务费用率上升,扣非后归母净利率略有下滑。风险提示生产安全事故及质量风险;制剂推广不及预期风险;订单交付波动性风险等","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103120314295bd9b32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103120314295bd9b32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2478307061","title":"太平洋:给予奥锐特买入评级,目标价位28.0元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478307061","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478307061?lang=zh_cn&edition=full","pubTime":"2024-10-27 16:50","pubTimestamp":1730019056,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司周豫,乔露阳近期对奥锐特进行研究并发布了研究报告《Q3收入及利润环比略有下滑,业绩基本符合市场预期》,本报告对奥锐特给出买入评级,认为其目标价位为28.00元,当前股价为22.89元,预期上涨幅度为22.32%。最新盈利预测明细如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.07。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700012835.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","601099"],"gpt_icon":0},{"id":"2478960944","title":"开源证券:给予奥锐特买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2478960944","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478960944?lang=zh_cn&edition=full","pubTime":"2024-10-25 17:39","pubTimestamp":1729849191,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,阮帅近期对奥锐特进行研究并发布了研究报告《公司信息更新报告:2024前三季度业绩高速增长,制剂业务快速放量》,本报告对奥锐特给出买入评级,当前股价为22.89元。最新盈利预测明细如下:该股最近90天内共有12家机构给出评级,买入评级9家,增持评级3家;过去90天内机构目标均价为29.07。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500032267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605116","161027"],"gpt_icon":0},{"id":"2478648297","title":"奥锐特大跌5.19% 6家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2478648297","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478648297?lang=zh_cn&edition=full","pubTime":"2024-10-25 09:30","pubTimestamp":1729819858,"startTime":"0","endTime":"0","summary":"10月25日,奥锐特股价大幅下跌,截至09点30分,奥锐特下跌5.19%,报22.45元/股,成交545万元,换手率0.06%,振幅4.98%。此外,数据统计显示,近半年内6家券商给予增持建议,13家券商给予买入建议。资金动向截止发稿,奥锐特获得主力净流出110万元,其中超大单流出111万元,大单流入1万元。最新财报显示,今年三季报,奥锐特实现营业收入10.88亿元,同比增长17.97%,净利润为2.84亿元,同比增长22.04%,基本每股收益为0.70元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025093659ab71d49e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025093659ab71d49e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2477076175","title":"奥锐特(605116.SH)发前三季业绩,净利润2.84亿元,同比增长22.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477076175","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477076175?lang=zh_cn&edition=full","pubTime":"2024-10-24 18:21","pubTimestamp":1729765291,"startTime":"0","endTime":"0","summary":"智通财经APP讯,奥锐特(605116.SH)发布2024年前三季度报告,报告期内公司实现营业收入10.88亿元,同比增长17.97%;归属于上市公司股东的净利润2.84亿元,同比增长22.04%;归属于上市公司股东扣除非经常性损益净利润2.82亿元,同比增长44.50%;基本每股收益0.70元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605116"],"gpt_icon":0},{"id":"2474053239","title":"奥锐特大跌5.03% 获主力净流入137万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474053239","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474053239?lang=zh_cn&edition=full","pubTime":"2024-10-11 14:43","pubTimestamp":1728628998,"startTime":"0","endTime":"0","summary":"10月11日,奥锐特股价大幅下跌,截至14点43分,奥锐特下跌5.03%,报22.28元/股,成交4808万元,换手率0.53%,振幅5.67%。资金动向截止发稿,奥锐特获得主力净流入137万元,其中超大单流入77万元,大单流入60万元。主营业务及业绩奥锐特公司主营业务为特色原料药和医药中间体的研发、生产和销售。最新财报显示,今年中报,奥锐特实现营业收入7.31亿元,同比增长32.21%,净利润为1.89亿元,同比增长96.66%,基本每股收益为0.46元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011144410a1dfe8b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011144410a1dfe8b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2474026297","title":"奥锐特大跌5.11% 获主力净流入增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2474026297","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474026297?lang=zh_cn&edition=full","pubTime":"2024-10-09 09:32","pubTimestamp":1728437577,"startTime":"0","endTime":"0","summary":"10月09日,奥锐特股价大幅下跌,截至09点32分,奥锐特下跌5.11%,报24.12元/股,成交604万元,换手率0.06%,振幅2.99%。资金动向截止发稿,奥锐特获得主力净流出98万元,其中超大单流出305万元,大单流入208万元。主营业务及业绩奥锐特公司主营业务为特色原料药和医药中间体的研发、生产和销售。最新财报显示,今年中报,奥锐特实现营业收入7.31亿元,同比增长32.21%,净利润为1.89亿元,同比增长96.66%,基本每股收益为0.46元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009133214ab68bac7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009133214ab68bac7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2473341614","title":"奥锐特10月08日主力资金流出1209万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2473341614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473341614?lang=zh_cn&edition=full","pubTime":"2024-10-08 15:17","pubTimestamp":1728371863,"startTime":"0","endTime":"0","summary":"10月08日, 奥锐特股价涨5.56%,报收25.42元,成交金额1.64亿元,换手率1.65%,振幅10.01%,量比2.53。奥锐特今日主力资金净流出1209万元,连续3日净流出,上一交易日主力净流出1461万元,今日环比减少17.25%。该股近5个交易日上涨22.80%,主力资金累计净流出2892万元;近20日主力资金累计净流出3823万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410081527459f314d67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410081527459f314d67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2473463014","title":"奥锐特创2个月新高 获主力净流入421万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473463014","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473463014?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:30","pubTimestamp":1728351003,"startTime":"0","endTime":"0","summary":"10月08日,奥锐特股价大幅上涨,截至09点30分,奥锐特上涨9.97%,报26.48元/股,创近2个月新高,成交252万元,换手率0.02%,振幅0.04%。资金动向截止发稿,奥锐特获得主力净流入421万元,其中超大单流入367万元,大单流入53万元。主营业务及业绩奥锐特公司主营业务为特色原料药和医药中间体的研发、生产和销售。最新财报显示,今年中报,奥锐特实现营业收入7.31亿元,同比增长32.21%,净利润为1.89亿元,同比增长96.66%,基本每股收益为0.46元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008100318a1ded076&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008100318a1ded076&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2471439822","title":"奥锐特09月30日遭主力抛售1461万元 环比增加769.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2471439822","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471439822?lang=zh_cn&edition=full","pubTime":"2024-09-30 15:17","pubTimestamp":1727680643,"startTime":"0","endTime":"0","summary":"09月30日, 奥锐特股价涨8.13%,报收24.08元,成交金额1.22亿元,换手率1.31%,振幅7.32%,量比2.86。奥锐特今日主力资金净流出1461万元,上一交易日主力净流出168万元,今日环比增加769.64%。该股近5个交易日上涨19.68%,主力资金累计净流出1438万元;近20日主力资金累计净流出2251万元,其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409301520459587708f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409301520459587708f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605116"],"gpt_icon":0},{"id":"2470717444","title":"奥锐特大幅上涨 2024河南与跨国公司合作交流会举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2470717444","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470717444?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:08","pubTimestamp":1727402890,"startTime":"0","endTime":"0","summary":"09月27日,奥锐特股价大幅上涨,截至10点08分,奥锐特上涨5.13%,报22.35元/股,成交2287万元,换手率0.26%,振幅4.84%。消息解读9月25日,2024河南与跨国公司合作交流会现代医药产业圆桌对接会在郑州举行。此次会议旨在深化河南与跨国公司在生物医药产业领域的务实合作,通过广泛深入交流,实现政企双向关注,推动与会企业与河南达成一批合作意向,助推河南生物医药产业高质量发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927101107a1dce21d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927101107a1dce21d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605116","BK0239"],"gpt_icon":0},{"id":"2469169643","title":"奥锐特09月23日主力资金流入196万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2469169643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469169643?lang=zh_cn&edition=full","pubTime":"2024-09-23 15:19","pubTimestamp":1727075941,"startTime":"0","endTime":"0","summary":"09月23日, 奥锐特股价跌0.30%,报收20.12元,成交金额2878万元,换手率0.36%,振幅2.38%,量比0.68。奥锐特今日主力资金净流入196万元,连续3日净流入,上一交易日主力净流入186万元,今日环比增加5.38%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为40.00%,平均涨幅为2.51%。该股近5个交易日下跌10.89%,主力资金累计净流出1347万元;近20日主力资金累计净流出1347万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409231533199f0f89e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409231533199f0f89e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605116"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-09-21","address":"浙江省台州市天台县八都工业园区","stockEarnings":[{"period":"1week","weight":-0.0113},{"period":"1month","weight":-0.0609},{"period":"3month","weight":-0.0171},{"period":"6month","weight":-0.0145},{"period":"1year","weight":-0.1351},{"period":"ytd","weight":-0.1435}],"companyName":"奥锐特药业股份有限公司","boardCode":"AI0027","perCapita":"44207股","boardName":"医药制造业","registeredCapital":"40619万元","compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.1808},{"period":"6month","weight":0.0911},{"period":"1year","weight":0.1074},{"period":"ytd","weight":0.1329}],"survey":" 奥锐特药业股份有限公司主营业务是特色原料药和医药中间体的研发、生产和销售。主要产品为呼吸系统类、心血管类、抗感染类和神经系统类药物,包括氟美松、丙酸氟替卡松、依普利酮、替诺福韦、普瑞巴林等原料药和中间体。公司已经通过了包括NMPA、FDA、WHO、BGV等监管机构的认证,目前已经有1个产品通过WHO的审计,4个产品取得欧盟CEP认证,3个产品取得了欧盟GMP证书,5个产品取得了出口欧盟的证明,11个产品已经提交了美国DMF文件,建立了独具竞争力的自主品牌,成为国内出口特色原料药较多的企业之一。","serverTime":1732264571395,"listedPrice":8.37,"stockholders":"8992人(较上一季度增加12.94%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥锐特(605116)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥锐特,605116,奥锐特股票,奥锐特股票老虎,奥锐特股票老虎国际,奥锐特行情,奥锐特股票行情,奥锐特股价,奥锐特股市,奥锐特股票价格,奥锐特股票交易,奥锐特股票购买,奥锐特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥锐特(605116)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥锐特(605116)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}